ReviewCureus2025
Enhanced Recovery After Surgery (ERAS) Protocols in Pancreatic Cancer Resections: Their Impact on Postoperative Morbidity.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The sole treatment for pancreatic cancer, which is a hazardous condition, is surgery, which has a high postoperative morbidity rate. Traditional perioperative care often makes the healing process more difficult and increases the risk of problems. The Enhanced Recovery After Surgery (ERAS) protocols that were created to address colorectal operations are intended to alleviate surgical trauma and promote recovery based on evidence-based, multimodal interventions. The current review will focus on the ongoing problem of the high rate of pancreatic resection morbidity and consider the effectiveness and applicability of ERAS in the same context. The aim is to critically evaluate clinical outcomes and barriers to implementation by performing a narrative synthesis of trials, observational studies, and meta-analyses. The important results imply that the use of ERAS protocols minimizes complications, decreases the length of hospital stays, and enhances recovery without mortality or readmission. Key challenges are the emphasis on protocol compliance, institutional issues, and limited representation of high-risk groups, namely, the elderly and infirm. The review concludes that, although ERAS has apparent advantages, its success is based on readiness, a robust multidisciplinary approach involving surgeons, anesthesiologists, nurses, dietitians, physiotherapists, and pain specialists to ensure coordinated care, and high protocol fidelity of the institution. The implications are that ERAS guidelines will have to be standardized, digital adherence tools will also be necessary, and multicenter trials will need to be inclusive of diverse patient populations. The review offers an elaborate model that can be used to achieve improved, fairer, and patient-centered perioperative care in pancreatic oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.